Systematic Reviews and Meta-Analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery
Lavikainen Lauri I.; Guyatt Gordon H.; Sallinen Ville J.; Karanicolas Paul J.; Couban Rachel J.; Singh Tino; Lee Yung; Elberkennou Jaana; Aaltonen Riikka; Ahopelto Kaisa; Beilmann-Lehtonen Ines; Blanker Marco H.; Cárdenas Jovita L.; Cartwright Rufus; Craigie Samantha; Devereaux P.J.; Garcia-Perdomo Herney A.; Ge Fang Zhou; Gomaa Huda A.; Halme Alex L.E.; Haukka Jari; Karjalainen Päivi K.; Kilpeläinen Tuomas P.; Kivelä Antti J.; Lampela Hanna; Mattila Anne K.; Najafabadi Borna Tadayon; Nykänen Taina P.; Pandanaboyana Sanjay; Pourjamal Negar; Ratnayake Chathura B.B.; Raudasoja Aleksi; ROTBIGGS Investigators; Vernooij Robin W.M.; Violette Philippe D.; Wang Yuting; Xiao Yingqi; Yao Liang; Tikkinen Kari A.O.
https://urn.fi/URN:NBN:fi-fe2025082786858
Tiivistelmä
Objective: To provide procedure-specific estimates of symptomatic venous thromboembolism (VTE) and major bleeding after abdominal surgery.
Background: The use of pharmacological thromboprophylaxis represents a trade-off that depends on VTE and bleeding risks that vary between procedures; their magnitude remains uncertain.
Methods: We identified observational studies reporting procedure-specific risks of symptomatic VTE or major bleeding after abdominal surgery, adjusted the reported estimates for thromboprophylaxis and length of follow-up, and estimated cumulative incidence at 4 weeks postsurgery, stratified by VTE risk groups, and rated evidence certainty.
Results: After eligibility screening, 285 studies (8,048,635 patients) reporting on 40 general abdominal, 36 colorectal, 15 upper gastrointestinal, and 24 hepatopancreatobiliary surgery procedures proved eligible. Evidence certainty proved generally moderate or low for VTE and low or very low for bleeding requiring reintervention. The risk of VTE varied substantially among procedures: in general abdominal surgery from a median of <0.1% in laparoscopic cholecystectomy to a median of 3.7% in open small bowel resection, in colorectal from 0.3% in minimally invasive sigmoid colectomy to 10.0% in emergency open total proctocolectomy, and in upper gastrointestinal/hepatopancreatobiliary from 0.2% in laparoscopic sleeve gastrectomy to 6.8% in open distal pancreatectomy for cancer.
Conclusions: VTE thromboprophylaxis provides net benefit through VTE reduction with a small increase in bleeding in some procedures (eg, open colectomy and open pancreaticoduodenectomy), whereas the opposite is true in others (eg, laparoscopic cholecystectomy and elective groin hernia repairs). In many procedures, thromboembolism and bleeding risks are similar, and decisions depend on individual risk prediction and values and preferences regarding VTE and bleeding.
Kokoelmat
- Rinnakkaistallenteet [29337]